1. Home
  2. CMRC vs VYGR Comparison

CMRC vs VYGR Comparison

Compare CMRC & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commerce.com Inc.

CMRC

Commerce.com Inc.

HOLD

Current Price

$2.68

Market Cap

227.7M

Sector

N/A

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.46

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMRC
VYGR
Founded
2009
2013
Country
United States
United States
Employees
1079
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
227.7M
203.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CMRC
VYGR
Price
$2.68
$3.46
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$4.88
$16.50
AVG Volume (30 Days)
655.8K
557.7K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
$5.11
$34.04
Revenue Next Year
$4.50
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.41
$2.83
52 Week High
$5.55
$5.55

Technical Indicators

Market Signals
Indicator
CMRC
VYGR
Relative Strength Index (RSI) 41.00 41.44
Support Level $2.43 $3.31
Resistance Level $3.13 $4.29
Average True Range (ATR) 0.16 0.20
MACD -0.04 -0.03
Stochastic Oscillator 9.08 24.35

Price Performance

Historical Comparison
CMRC
VYGR

About CMRC Commerce.com Inc.

Commerce.com Inc is engaged in offering a Software-as-a-Service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which the majority of its revenue is generated from Americas-U.S.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: